MaxCyte, Inc. Share Price
MXCTMaxCyte, Inc. Stock Performance
Open $0.81 | Prev. Close $0.82 | Circuit Range N/A |
Day Range $0.79 - $0.83 | Year Range $0.65 - $2.88 | Volume 5,220 |
Average Traded $0.81 |
MaxCyte, Inc. Share Price Chart
About MaxCyte, Inc.
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
MaxCyte, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
28-Apr-26 | $0.87 | $0.88 | +0.34% |
27-Apr-26 | $0.85 | $0.88 | +1.74% |
24-Apr-26 | $0.84 | $0.86 | -0.69% |
23-Apr-26 | $0.86 | $0.87 | -2.26% |
22-Apr-26 | $0.87 | $0.89 | +1.96% |
21-Apr-26 | $0.85 | $0.87 | +1.52% |
20-Apr-26 | $0.83 | $0.86 | +0.59% |